Mikrogen Diagnostik recomWell EBV IgM ELISA Kit (7205)
$475.00
| Host | Quantity | Applications | Species Reactivity | Data Sheet | |
|---|---|---|---|---|---|
| 96 Tests | ELISA | Epstein Barr Virus |  |
Overview
Product Name Mikrogen Diagnostik recomWell EBV IgM ELISA Kit (7205)
Description Enzyme immunoassay with antigens produced by recombinant techniques for the detection of IgG and IgM antibodies against Epstein-Barr Virus (EBV)
Target Human Epstein Barr Virus IgM
Species Reactivity Epstein Barr Virus
Assay Type Indirect ELISA
Applications ELISA
Properties
Background The Epstein-Barr virus, an ubiquitously occurring herpes virus, can cause the symptoms of infectious mononucleosis (Pfeiffer´s disease) on primary infection. Moreover, as a result of the lifelong persistence of this pathogen, reactivations can occur, especially in immuno-incompetent persons.
Due to the diversity of symptoms caused by EBV infection and their correspondence with the symptoms of other diseases, a secure EBV diagnosis is of great relevance for differential diagnostics. One of the main tasks in routine diagnosis is therefore the serological differentiation of a primary infection from a past infection and the exclusion of an EBV infection.
The recomWell EBV ELISA test systems are highly sensitive screening tests for detection of Epstein-Barr virus antibodies (IgG, IgM). Due to genetical engineering highly specific and characteristic EBV proteins can be used. A classification into the different stages of infection (primary infection, past infection) is possible due to the time-shifted appearance of antibodies against different EBV antigens.
Due to the diversity of symptoms caused by EBV infection and their correspondence with the symptoms of other diseases, a secure EBV diagnosis is of great relevance for differential diagnostics. One of the main tasks in routine diagnosis is therefore the serological differentiation of a primary infection from a past infection and the exclusion of an EBV infection.
The recomWell EBV ELISA test systems are highly sensitive screening tests for detection of Epstein-Barr virus antibodies (IgG, IgM). Due to genetical engineering highly specific and characteristic EBV proteins can be used. A classification into the different stages of infection (primary infection, past infection) is possible due to the time-shifted appearance of antibodies against different EBV antigens.
Sample Type Serum, plasma, whole blood
Assay Resolution See Figure
Components
| 10X Wash Buffer | 100 mL |
| Dilution Buffer | 125 mL |
| TMB Substrate | 12 mL |
| Stop Slution | 12 mL |
| Instuctions for Use | 1 Each |
| Evaluation Form | 1 Each |
| Microplate Sealing Tape | 2 Each |
| Microtiter Plate | 12 x 8 Wells |
| Positive Control | 450 uL |
| Cut-Off Control | 450 uL |
| Negative Control | 450 uL |
| Anti-Human IgM Conjugate | 500 uL |
Specificity Information
Target Name Epstein Barr Virus
Target ID Human Epstein Barr Virus IgM
Alternative Names EBV
Research Areas Infectious Disease
Application Images
Description Test Principle
Description Evaluation
Additional Information
Additional Information Additional Mirkogen Kit Information
Handling
Storage Store at 2 - 8°C until expiration on packaging.
References & Data Sheet
Data Sheet 
Download PDF Data Sheet
Download PDF Data Sheet